Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 10, 2025 05:00 ET | Source: NUCLIDIUM AG

NUCLIDIUM Closes CHF 79 Million (EUR 84 Million) Series B Financing to Advance Clinical Development of its Copper-based Radiopharmaceutical Platform

Proceeds will fund further clinical development of the company’s true theranostic pipeline and expansion of the global production and manufacturing network for copper-based...
June 24, 2025 05:00 ET | Source: NUCLIDIUM AG

NUCLIDIUM Presents Positive Phase 1 Results of its Novel PET Imaging Agent 61Cu-NuriPro™ at SNMMI 2025 Annual Meeting

61Cu-NuriPro™ detected more lesions up to 4 hours post-administration in 50% of patients, not visualized by 18F-piflufolastat PET1,2 Dosimetry data highlight favorable tumor-to-background ratio with...